 |
-
The AIC Diversified Science & Technology Fund: Peter Hofstra, AIC Investment Services Inc.
-
Investing in Emerging Markets: Charles Wang, Acadian Asset Mgmt.
-
The Enterprise Portfolio: Jonathan Raclin, Barrington Asset Management, Inc.
-
Investing in Diabetes-Related Stocks: David Kliff, Diabetic Investor
-
Asset Allocation & Tactical Financial Planning: Jeff Eisfelder, Lido Advisors, Inc.
Topics covered: Large technology companies - Underlying demand for technology - Healthcare science - Good opportunities in emerging markets - Frontier markets - Changing global economic environments - Diabetes care industry - Correlation between obesity and pre-diabetes - New technologies and promising products - Tactical asset allocation - Oil and gas exploration - Hedge fund strategies
Companies covered: Dell (DELL), Microsoft (MSFT), Research in Motion (RIMM), Google (GOOG), Apple Computer (AAPL), Adobe Systems (ADBE), Pall (PLL), Medtronic (MDT), QUALCOMM (QCOM), Novo Nordisk (NVO), Sanofi-Aventis, (SNY), DexCom (DXCM), MannKind (MNKD), Eli Lilly (LLY), Amylin Pharmaceuticals (AMLN), Abbott Laboratories (ABT), Emisphere Technologies (EMIS), Alkermes (ALKS), Arena (ARNA), Pfizer (PFE).
This Issue
costs $175 - and is non-returnable.
The Wall Street Transcript
does not endorse the views of any interviewee nor does it make stock recommendations.
|
 |

Investors and Industry Execs.
The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.
TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best.
Money manager interviews provide the view from the buy-side.
CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.
Subscribe to a unique research tool for investors and industry executives. Call
(212) 952 7433 or click here.
Sincerely,
Andrew Pickup
Publisher
|
|
 |